How Fermentation Increases the Bioavailability of Nutrients Your Body Needs

This article is for educational purposes only and does not constitute medical advice.

Taking a supplement or consuming a beneficial food compound is not the same as actually absorbing and using that compound. Bioavailability — the proportion of an ingested substance that reaches systemic circulation and is available to exert biological effects — is a critical and often overlooked dimension of nutritional science.

For people with sickle cell disease who are consuming plant-based compounds for their anti-sickling and antioxidant properties, understanding how fermentation dramatically improves bioavailability is directly relevant to the efficacy of their supplementation strategy.

What Is Bioavailability?

Bioavailability refers to the fraction of an ingested compound that reaches the systemic circulation and becomes available for biological activity at the cellular level. A compound with 100% bioavailability is completely absorbed and enters circulation unchanged. Most dietary compounds have bioavailability well below 100% due to multiple barriers: degradation in the stomach's acidic environment, incomplete absorption in the small intestine, first-pass metabolism in the liver that deactivates compounds before they enter general circulation, and binding to other dietary components that prevent absorption.

For many plant-derived bioactive compounds — polyphenols, phytochemicals, and alkaloids — bioavailability is particularly variable and often low in their natural form. This is not a failure of the plant or the supplement; it is the inherent challenge of extracting biological activity from complex natural matrices.

The Barriers to Plant Compound Bioavailability

Glycoside Bonding

Many plant polyphenols — including flavonoids like luteolin, quercetin, and apigenin, which are the anti-sickling compounds in sorghum bicolor — exist in plants primarily as glycosides: they are bound to sugar molecules. In this form, they cannot be directly absorbed through the intestinal wall. They must first be cleaved by enzymes (either intestinal brush-border enzymes or gut bacterial enzymes) to release the active aglycone form.

The efficiency of this cleavage depends heavily on the health and composition of an individual's gut microbiome. In people with gut dysbiosis — which includes many SCD patients, as documented in microbiome research — the bacterial enzyme activity needed to cleave glycoside bonds is reduced. The compounds may pass through the gut largely unabsorbed.

Fermentation solves this problem by performing the glycoside cleavage before the compound reaches the gut, converting polyphenol glycosides into their more bioavailable aglycone forms during the fermentation process itself.

Anti-Nutrient Binding

Plant seeds, legumes, and grains contain anti-nutritional compounds — particularly phytic acid (phytate) — that form tight complexes with minerals and some polyphenols, preventing their absorption in the gastrointestinal tract. Phytate binds iron, zinc, magnesium, and calcium particularly strongly; the phytate:zinc and phytate:iron ratios in food are major determinants of how much of these minerals actually get absorbed.

The enzyme phytase, produced by certain bacteria and yeast during fermentation, breaks down phytic acid and releases the bound minerals and polyphenols. This is why zinc and iron from fermented legumes and grains are significantly more bioavailable than from their unfermented equivalents. For SCD patients with zinc deficiency (common in SCD), this can be clinically meaningful.

Cell Wall Entrapment

Plant cell walls are composed of complex polysaccharides (cellulose, hemicellulose, pectin) that form a physical barrier around the cells containing bioactive compounds. Human digestive enzymes cannot efficiently break down these cell walls; only microbial cellulases and hemicellulases can. Fermentation pre-digests cell walls, releasing the intracellular contents into a form that can be directly absorbed without relying on the consumer's digestive capacity.

Protein Binding

Many bioactive compounds bind to proteins in food, forming complexes that are resistant to digestion. Fermentation's protease activity partially hydrolyzes these proteins, releasing bound compounds and making them available for absorption.

Solubility Issues

Some bioactive compounds have limited water solubility, which reduces their interaction with the aqueous intestinal environment and impairs absorption. Fermentation can modify the chemical structure of compounds to improve their solubility through biotransformation reactions.

What the Research Shows: Documented Bioavailability Enhancement

The bioavailability improvements from fermentation are not theoretical — they have been measured in multiple research studies:

• Lunasin from soybeans: Fermented soy products show 5-10x higher lunasin activity than unfermented soy
• Iron from cereal grains: Phytase production during lactic acid fermentation of millet and sorghum reduces phytate content by 80–90% and increases iron absorption by 2–4x in human feeding studies
• Zinc from legumes: Fermentation reduces phytate in legumes and significantly improves zinc bioavailability — important for SCD patients with zinc deficiency
• Polyphenols from plant extracts: Multiple studies comparing fermented and non-fermented plant extracts have found substantially higher plasma polyphenol levels following consumption of fermented versions, with differences ranging from 2x to more than 10x
• GABA production: Certain lactic acid bacteria produce gamma-aminobutyric acid (GABA) during fermentation of plant materials, transforming glutamic acid into a bioactive compound not present at significant levels in the original material

Fermentation and the Gut Microbiome Dependency Problem

An underappreciated dimension of polyphenol bioavailability is its dependence on gut microbiome composition. Many polyphenols require specific gut bacterial transformations to produce their most bioactive metabolites:

• Ellagitannins (in pomegranate, berries) must be converted by gut bacteria to urolithins — the most bioactive metabolites — but only about 40% of people have the gut bacterial profile needed to make this conversion efficiently
• Lignans from flaxseed require conversion by gut bacteria to enterolactone and enterodiol for maximal anti-inflammatory activity
• Isoflavones from soy require bacterial conversion to equol in the colon for maximum activity

Fermentation circumvents this problem by performing the biotransformation before ingestion. The active forms are already present in a fermented supplement, making the benefit independent of the consumer's gut microbiome composition.

Why This Matters for SCD Botanical Supplementation

The anti-sickling and antioxidant compounds in sorghum bicolor — luteolin, apigenin, and vitexin — exist primarily as glycosides in the raw plant material. The fermentation process applied in HalfMoon Labs' Fermented Sorghum & Papaya supplement cleaves glycoside bonds to produce free aglycone forms of the anti-sickling flavonoids, breaks down plant cell walls to release intracellular contents, reduces anti-nutrient interference with absorption, pre-converts polyphenols into forms bioavailable independent of gut microbiome status, and produces additional bioactive compounds (postbiotics) through microbial metabolism.

See our full guides: The Plants Behind Our Formula and Why Fermented Sorghum and Papaya Is Different.

Frequently Asked Questions

Q: If I have good gut health, do I still benefit from fermented supplements?
Yes. Even with excellent gut health, fermented supplements provide pre-converted compounds in immediately bioavailable form, meaning faster absorption and more consistent dosing. Additionally, the fermentation process produces postbiotic compounds not present in unfermented raw materials, adding bioactive value beyond mere bioavailability improvement.

Q: Does fermentation increase all plant compounds equally?
No. The enhancement is compound-specific and depends on the type of fermentation, the microbial species involved, and the chemistry of the compounds in the substrate. This is why the specific choice of fermentation microorganism and process matters for the quality of the final supplement.

Q: How do I know if my gut microbiome is impaired in ways that affect absorption?
Common signs suggesting gut dysbiosis include chronic digestive symptoms, history of frequent antibiotic use (very common in SCD), and nutrient deficiencies despite adequate dietary intake.

Q: Is fermented better than extract for these compounds?
For SCD patients specifically, given documented gut dysbiosis, fermented preparations offer the advantage of bioavailability independence from gut microbiome status.

Q: Does cooking or storage degrade the fermentation-enhanced compounds?
Most of the bioavailability enhancements from fermentation survive typical processing and storage temperatures. Unlike live cultures, which are killed by heat, the chemical transformations produced by fermentation are largely stable.

Key Takeaways

• Bioavailability is often low for unprocessed plant compounds due to glycoside bonding, anti-nutrient binding, cell wall entrapment, and protein binding
• Fermentation improves bioavailability by cleaving glycoside bonds, breaking down anti-nutrients, digesting cell walls, and pre-converting polyphenols into their most active forms
• Many polyphenols require gut bacterial biotransformation to produce their most bioactive metabolites; SCD patients with gut dysbiosis may have impaired biotransformation capacity
• Fermentation pre-performs this biotransformation, making active compounds available independent of the consumer's gut microbiome status
• Documented enhancements include 2–10x higher polyphenol absorption, 2–4x higher iron absorption, and significantly improved zinc bioavailability

External Sources:
PubMed: Bioavailability enhancement through fermentation
PubMed: Gut microbiome dysbiosis in SCD
Sickle Cell Disease Association of America

Related Reading:
What Is Fermentation?
Why Fermented Sorghum and Papaya Is Different
Postbiotics 101

This article is for educational purposes only. HalfMoon Labs products are not intended to diagnose, treat, cure, or prevent any disease. Always work with your hematologist and care team for treatment decisions.